Phát hiện mới về hiệu quả mũi tăng cường của vaccine Pfizer/BioNTech

Theo một nghiên cứu mới được đăng tải trên tạp chí khoa học Nature Immunology ngày 9/5, dựa trên các thông số thu được từ xét nghiệm PCR, mũi thứ 3 vaccine ngừa COVID-19 của Pfizer/BioNTech đạt hiệu quả phòng bệnh ước tính ở mức 85,6% so với việc chỉ tiêm hai mũi cơ bản.

4bu2Yj8qw6DDqj7hu4/hu4/GryXDs8OVY8O1w6rDoyXhu7jDk2J7w7UqYmPhuqXhu4Eq4bq/a2MqcMOiKmJj4bqlw7Qqw7LDtF0q4bq/4buXYyrDtSDhu4Hhuqsqw6DGoWzhu4Hhuqsqw6Dhu5U+KnA+w6DDoGPhu4HDoyrDk+G6qWN6w6Phu40vw4Fj4buH4buAw5XDo8OgYuG7ti9iP+G7uOG7tsOzKsOgw6o+4buP4buPxq8lw7PDgeG7h+G6oXMl4bu44bu2Y+G6v+G6qyrDoMOqPuG7j+G7j8avJcOg4bq/4buPLcOzYuG7h8O14buHJSrDtWPDtcOqw6PGryXDk2J7w7UqYmPhuqXhu4Eq4bq/a2MqcMOiKmJj4bqlw7Qqw7LDtF0q4bq/4buXYyrDtSDhu4Hhuqsqw6DGoWzhu4Hhuqsqw6Dhu5U+KnA+w6DDoGPhu4HDoyrDk+G6qWN6w6Phu40vw4Fj4buH4buAw5XDo8OgYipixJHhu4FiKl3hu4FiKj8lKuG7j+G7jcOgxq8lLy/DoFnDoT7hu4fDtWI+4buBYmLhu4c+WXDhu4EvY+G6v+G6qy/huqHDo+G7j+G6vcO14buHw7Mv4buBw6Nx4buPLzo6PzwvPygo4bqhOyY8Pyg6LMO1IT86w6o/WXHDo8Ohw7MlKj7DqsO1xq8lw5Nie8O1KmJj4bql4buBKuG6v2tjKnDDoipiY+G6pcO0KsOyw7RdKuG6v+G7l2Mqw7Ug4buB4bqrKsOgxqFs4buB4bqrKsOg4buVPipwPsOgw6Bj4buBw6Mqw5PhuqljesOj4buNL8OBY+G7h+G7gMOVw6PDoGIlKuG6oT7DtT4tw7Ni4buHw7Xhu4ct4buH4buNY+G6q2Phu4E+w6ot4buP4buNw6DGryViw7XDtcOz4buPVi8vw6DhuqHhu4Fj4bq/4bqrWXBjw6PDteG7gT7hur/Ds8Oqw7Thu49ZcOG7gS/DtSE6Ji/DtMOzw6rhu4c+4bqhw6PhuqEv4buB4bqrw7Xhur/DoWIvOiY6Ol8mLl8/Ji/DtcO1cnDhu4FfX3A+w6DDoGPhu4HDo19fw7PhuqljesOj4buNw6Fj4buH4buBw7XDo8OgYlnhurvDs+G6qyUqL+G7uFA+w6DDoGPhu4HDoyrhu4Hhuqvhu50+KsOA4buGUEPhuqAtPzwqw6Dhu5U+KsOT4bqpY3rDo+G7jS3DgWPhu4fhu4DDlcOjw6BiWSrhu7Lhu6vhu4FiVirhu6fhuqjDky/DlcOVUlDhu4Dhu7Thu7Yvw7Phu7jhu7bDsyrDoMOqPuG7j+G7j8avJcOzQsOjPuG6oSXhu7jDlWLDo+G7hyrhur/hu4vDtSrhu4HhuqtiY+G6s+G7gSrDoOG7m8O0KuG6v2tjKuG6o8ahbcOgKuG6oyDhu4Hhuqsqw7VdYyrDteG7jeG6s+G7gSrDtVvDsyrDoGJkKuG6vWLhu4c+KmJmw6Aq4buAPsO1w7Thu43DoypD4bq/4bq/w7Thu4Hhu4fDquG7h+G6q3Mq4buB4bqrfXMqPC8uWCrhuqHhu6M+KsO14buN4bqz4buBKsOge8OgKsO1Ymnhu4Hhuqsq4buPw60qw7Viw7Qq4bqjxqFtw6Aqw7Xhu50qcsSDw7Uq4buB4bqrYmPhuqXhur8qw5PDgOG7jFgq4bq/4buXYyrDtWLhu5sqOypwPsOgw6Bj4buBw6Mq4buB4bqr4budPirDgOG7hlBD4bqgLT88KsOg4buVPirDk+G6qWN6w6Phu40vw4Fj4buH4buAw5XDo8OgYirhuqNbw7UqYmPhuqXDtCrDssO0XSrDs2Lhu4Xhu4Hhuqsqw6HhuqXhu4FiKsaha8OgKsO1ZOG7gWIqbirhur/hu5vDoCopLlgh4buqKuG7j+G7hypwa2MqcGPhuqXDoCrDoGLDqSrDtWPhurPhur8qYj5jKuG6v+G7l2Mqw6BqKsOhXeG7gVnhu7Yvw7Phu7jhu7bDsyrDoMOqPuG7j+G7j8avJcOzw4Hhu4fhuqFzJeG7uOG7gGLhu4Phur8q4buB4bqrYmPhurPhu4Eqw6Dhu5vDtCpD4buP4buNPsOjw6oqw7VbYyrDleG7jcO04buB4bqrKsO1NeG6vypTKuG6vWLhu4c+KuG7jmLDo8OhPipwfSrhuqJbYypiZsOgKsOVw6PDqirhu6dwY3Aq4buB4bqzw7Qq4buNaCpiZirhuqMiKsO1YuG7nyrhu4HhuqtiY+G6peG6vyrDtWPhurPhur8q4bq/4buXYyrDtWLhu5sqw6E+KnA+w6DDoGPhu4HDoyrDoOG7lT4qw5PhuqljesOj4buNL8OBY+G7h+G7gMOVw6PDoGIqw6Bi4buHKj86WTo8Jirhu4FiNeG7gSpwY+G6s+G7gSpzKsO14bq1KsOgYsahPirDteG7neG7geG6qyrhur8ww6Aqw4Dhu4ZQQ+G6oC0/PCpwfSrhuqMiKsO1Y+G6s+G6vyrhuqPhu5UqYj5jKuG6v+G7l2Mqw6BqKsOhXeG7gSrDteG7jcaha8OgKuG6o+G7g1nhu7Yvw7Phu7jhu7bDsyrDoMOqPuG7j+G7j8avJcOzw4Hhu4fhuqFzJeG7uOG6vOG6tcO1KsOyw7RdKnLEg8O1KuG7geG6q2Jj4bql4bq/KsOTw4Dhu4wq4buPPsO0KuG6v+G7i8O1KsO1YmxjKuG6q2M+4buBKsO1Y+G6s+G6vyrDs2Lhu4Xhu4Hhuqsq4buBYjbDtSrhuqNl4buBYirDoGLhu4cqw7ViNnMqw7Xhu43hu4fhu4Hhuqsq4buPw60q4buBfXMqw6Biw6kqw6Dhu4MqLCYoKuG7geG6q8ahbGMq4bqhxqFq4buB4bqrKsO1ZOG7gWIqcGtjKnBj4buNw7Thu48q4buO4bun4buM4buOLcOA4buHUC06WeG7ti/Ds+G7uOG7tsOzKsOgw6o+4buP4buPxq8lw7PDgeG7h+G6oXMl4bu4Qj5jKsO14buNxqFs4buB4bqrKmJtw7Mq4bq9YnvDoCrDs2JdYyrhu4FiOMOzKnBj4bql4buBKuG6oeG7hyrDoOG7gyrDs2Jd4buBKuG7m+G7geG6qyrDs2Lhu5kq4buPPsO0KsO1Y+G6s+G6v1gqw7Xhu43hu4fhu4Hhuqsq4bqj4buDKuG6v+G7i8O1KuG7geG6q8ahbGMq4bqrMsOzKsOgYuG7m+G7geG6qyrhuqM+w7Qq4buB4bufPirhuqM3w7Qq4bq9w6jhur8qw6Fj4bqnw7QqYmPhuqXhu4Eq4bq/NsO1KuG6q2N7w6Aqw7LDtD7hu4Eq4buBMeG6vypwY+G6peG7gSrDteG7jeG7h+G7geG6qypiPmMq4buB4bqrfXNXKuG7geG6q8ahbGMqw6Dhu4Xhu4Eqw6pbYyrDoWUqYlsq4buBPsO14buNYyrhur97w7Qq4bq9Ymnhu4Hhuqsq4buNaCrhu4HhuqvDtHPhurPhu4Eq4buBYjXhu4FYKuG6o8ahbcOgKnLDtDbDtSpwY+G6peG7gSrhu48+w7QqLCrhu4Hhuqt9c1nhu7Yvw7Phu7jhu7bDsyrDoMOqPuG7j+G7j8avJcOzw4Hhu4fhuqFzJeG7uMOTYjfhu4Eqw6pr4buBKuG7gWI14buBKnBj4bqz4buBKnMqw7XhurUqw7ViPuG6vyrhuqtjPirhu4HhuqtiY+G6s+G7gSrDoOG7m8O0KsOgYuG7hyrDoWPhurXDtSpiZirDoF3hur8qw7ViNnMq4buPxqHhu4Hhuqsq4bqjPsO0KsO1W2Mqw6BixKkq4bq9YmMqw7Vj4bqz4bq/KuG6v+G7l2Mqw7Vi4bubKsOhPlnhu7Yvw7Phu7jhu7bDsyrDoMOqPuG7j+G7j8avJcOzw4Hhu4fhuqFzJeG7uMOTYuG7mSrhu4Hhu6Eq4bqhxqFrYyohJirDtcO04buJYyrhuqtiYyrhu4FiOOG7gSrhu4FiY8Oiw7Qqw7Xhu41j4bqlw7Qqw6Bi4bub4buB4bqrKuG7jz7DtCrDtWPhurPhur8qYmrhu4Eq4buP4buHKnBrYyrDoTbDtSrhur11KuG7gWLhu4Phur8qw7XDtOG7iWMqYuG7hzLDoCrhuqtja2Mqw7Vk4buBYirhu4F94buHKuG6vWJ7w6Aqw7Xhu43hu4fhu4Hhuqsq4buPw60q4buBYuG7oeG7geG6qyrhu4HhuqvGoWxjKsO1Yj7hur8q4bqrYz4q4buB4bqrYmPhurPhu4Eqw6Dhu5vDtFnhu7Yvw7Phu7jhu7bDsyrDoMOqPuG7j+G7j8avJcOzw4Hhu4fhuqFzJeG7uOG7gOG7oSrhuqtja2Mqw7Xhu43hurEqw7XDtOG7iWMqYmrhu4Eqw6Dhu5fhu4Hhuqsqw6Bi4buHKsOhY+G6tcO1KmJmKuG6qzLDsyrhu4FiY8Oiw7Qqw7NiXeG7gSrhu5vhu4Hhuqsqw7Ni4buZKsO1W2Mq4buBYmPDosO0KuG6vWLDtCpw4bujw6Aq4bq9YnvDoCrhu4FiPsO0KsO14buN4bqz4buBKsOgairDtWLhuqcq4buP4buHKnBrYyrDoHvDoCrhu4Fi4buD4bq/KuG6vWJ7w6BYKsOhPuG7hyrhuqvDrOG6vyrhur/huqXDtSrhur9nY1gq4bqjPsO0KsOgaipwfSrhu4/DrcO1WeG7ti/Ds+G7uOG7tsOzKsOgw6o+4buP4buPxq8lw7PDgeG7h+G6oXMl4bu44buA4bqrYmPhurPhu4Eqw6Dhu5vDtCrDoGLhu4cqw6Fj4bq1w7Uqw7Vi4bqz4bq/KuG6v+G7l2Mqw7Vi4bubKsOhPipwPsOgw6Bj4buBw6Mqw6Dhu5U+KsOT4bqpY3rDo+G7jS/DgWPhu4fhu4DDlcOjw6BiKnDDoirDoGoqw6Fd4buBKuG7j2Phu4FiKsOqxqFt4buB4bqrKuG6vWJ74buB4bqrKsO1YuG6pyrDoD7hu4cqYmrhu4Eq4bq/4buXYyrDtWLhu5sqYj5jWCpww63hu4EqYmPhuqXDtCrDssO0XSrhuqtjXeG6vyrhuqE34buBKsO14budKi4tISrDtWJ74buB4bqrKuG7jz7DtCrhur1iYyrDtWPhurPhur9Z4bu2L8Oz4bu44bu2w7Mqw6DDqj7hu4/hu4/GryXDs8OB4buH4bqhcyXhu7jDlWLDo+G7hyrhuqHhu6Eqw6pj4bqlw7Qqw7Viw7Qqw7ViOMOzKuG6o8ahbcOgKsO14buN4buH4buB4bqrKuG6vWLDtGnhu4Eq4bq9YuG7iSrhu4HhuqtiY+G6s+G7gSrDoOG7m8O0WCrhuqHhu5Mqw6rGoW3hu4Hhuqsq4bq9Ynvhu4Hhuqsqw7Vi4bqnKsO1IOG7geG6qyrDtcahauG7geG6qyrhuqPDrWMqZMO1WCrDoGLDqSrhur1i4buHXeG7geG6qyo/WCgqw6o34buBWCrhu4FixqHhu4HhuqsqYmPhuqXDtCrDssO0XSrDteG7jcO04buB4bqrKmLhu4U+KuG6vWJ74buB4bqrKsO1YuG6pyrDteG7jeG7h+G7geG6qyrhur97w7Qqw7Ug4buB4bqrKuG6qzbDsyohKsOqN+G7gSrhu4/hu4cqcGtjKuG7jz7DtCrhur1iYyrDtWPhurPhur8q4bq/4buXYyrDtWLhu5sqYj5jWS9Z4bu2L8Oz4bu44bu2w7Mqw6DDqj7hu4/hu4/GryXDs+G7p8O0w7Vi4buH4buNJeG7uOG7ssOVw5VSUOG7gC9QY8Ojw7Xhu4E+4bq/K+G7tOG7ti/Ds+G7uA==

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Thế giới
(Baothanhhoa.vn) - Theo thông báo của Bộ Tài chính Israel, chi phí từ xung đột giữa Israel và Iran đang gia tăng nhanh chóng, với ước tính chi phí trực tiếp từ xung đột với Iran kể từ cuối tháng 2/2026 đã lên tới khoảng 35 tỷ shekel (tương đương 11,5 tỷ USD).
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh